help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2004-0063
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elsasser, T. H.
Right arrow Articles by Li, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elsasser, T. H.
Right arrow Articles by Li, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-TYROSINE
*NITRIC OXIDE
*NITROGEN
Endocrinology Vol. 145, No. 7 3413-3423
Copyright © 2004 by The Endocrine Society

Mechanisms Underlying Growth Hormone Effects in Augmenting Nitric Oxide Production and Protein Tyrosine Nitration during Endotoxin Challenge

Ted H. Elsasser, Stanislaw Kahl, Carol MacLeod, Benjamin Nicholson, James L. Sartin and Congjun Li

Growth Biology Laboratory, United States Department of Agriculture, Agricultural Research Service (T.H.E., S.K., C.L.), Beltsville, Maryland 20705; Cancer Center, University of California San Diego (C.M., B.N.), La Jolla, California 92093; and Department of Anatomy, Physiology & Pharmacology (J.L.S.), Auburn University, Auburn, Alabama 36849

Address all correspondence and requests for reprints to: Dr. Ted H. Elsasser, United States Department of Agriculture, Agricultural Research Service, Growth Biology Laboratory, B-200, Room 201, Beltsville Agricultural Research Center-East, Beltsville, Maryland 20705. E-mail: elsasser{at}anri.barc.usda.gov.

The present study defined the effects of GH administration on components of the nitric oxide (NO)-generating cascade to account for observed increases in NO production and protein nitration after an immune challenge. Calves were assigned to groups with or without GH treatment (100 µg GH/kg body weight or placebo im, daily for 12 d) and with or without low-level endotoxin [lipopolysaccharide (LPS), 2.5 µg/kg, or placebo, iv]. Plasma was obtained for estimation of NO changes as [NO2 + NO3] (NOx). Transcutaneous liver biopsies were collected for measurement of protein tyrosine nitration, cationic amino acid transporter (CAT)-2 mRNA transporter, and constitutive NO synthase (cNOS), inducible NOS (iNOS), and arginase activity. Liver protein nitration increased more than 10-fold 24 h after LPS and an additional 2-fold in animals treated with GH before LPS. GH increased plasma NOx after LPS to levels 27% greater than those measured in non-GH-treated calves. LPS increased CAT-2 mRNA after LPS; GH was associated with a 24% reduction in CAT-2 mRNA content at the peak time response. cNOS activity was 3-fold greater than iNOS after LPS. NOS activities were increased 140% (cNOS) at 3 h and 169% (iNOS) at 6 h, respectively, after LPS; GH treatment increased cNOS activity and the phosphorylation of endothelial NOS after LPS more than 2-fold over that measured in non-GH-treated calves. The data suggest that an increased production of nitrated protein develops in the liver during low-level, proinflammatory stress, and nitration is increased by GH administration through a direct effect on the competing activities of NOS and arginase, modulatable critical control points in the proinflammatory cascade.




This article has been cited by other articles:


Home page
J ANIM SCIHome page
J. L. Sartin, D. L. Marks, C. D. McMahon, J. A. Daniel, P. Levasseur, C. G. Wagner, B. K. Whitlock, and B. P. Steele
Central role of the melanocortin-4 receptors in appetite regulation after endotoxin
J Anim Sci, October 1, 2008; 86(10): 2557 - 2567.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Grasemann, F. Ratjen, D. Schnabel, E. Reutershahn, U. Vester, and H. Grasemann
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients
Eur. Respir. J., April 1, 2008; 31(4): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
T. H. Elsasser, T. J. Caperna, C-J. Li, S. Kahl, and J. L. Sartin
Critical control points in the impact of the proinflammatory immune response on growth and metabolism
J Anim Sci, April 1, 2008; 86(14_suppl): E105 - E125.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. H. Elsasser, C.-J. Li, T. J. Caperna, S. Kahl, and W. F. Schmidt
Growth Hormone (GH)-Associated Nitration of Janus Kinase-2 at the 1007Y-1008Y Epitope Impedes Phosphorylation at This Site: Mechanism for and Impact of a GH, AKT, and Nitric Oxide Synthase Axis on GH Signal Transduction
Endocrinology, August 1, 2007; 148(8): 3792 - 3802.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. H. Elsasser, S. Kahl, C.-J. Li, J. L. Sartin, W. M. Garrett, and J. Rodrigo
Caveolae Nitration of Janus Kinase-2 at the 1007Y-1008Y Site: Coordinating Inflammatory Response and Metabolic Hormone Readjustment within the Somatotropic Axis
Endocrinology, August 1, 2007; 148(8): 3803 - 3813.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Aisemberg, C. Vercelli, S. Billi, M. L. Ribeiro, D. Ogando, R. Meiss, S. M. McCann, V. Rettori, and A. M. Franchi
Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption
PNAS, May 1, 2007; 104(18): 7534 - 7539.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Christen, I. Cattin, I. Knight, P. G. Winyard, J. W. Blum, and T. H. Elsasser
Plasma S-Nitrosothiol Status in Neonatal Calves: Ontogenetic Associations with Tissue-Specific S-Nitrosylation and Nitric Oxide Synthase
Experimental Biology and Medicine, February 1, 2007; 232(2): 309 - 322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Daniel, T. H. Elsasser, A. Martinez, B. Steele, B. K. Whitlock, and J. L. Sartin
Interleukin-1{beta} and tumor necrosis factor-{alpha} mediation of endotoxin action on growth hormone
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E650 - E657.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. H. Elsasser, J. W. Blum, and S. Kahl
Characterization of calves exhibiting a novel inheritable TNF-{alpha} hyperresponsiveness to endotoxin: associations with increased pathophysiological complications
J Appl Physiol, June 1, 2005; 98(6): 2045 - 2055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society